Nav1.8 inhibition in Purkinje fibers attenuates INa,L, shortens APD, and suppresses EADs, highlighting its potential as a therapeutic target for arrhythmias associated with bradycardia. This evidence concerns the gene SCN10A and Arrhythmia.